Gynecologic Cancer
Conference Coverage
‘Huge step forward’ in advanced ovarian cancer
A preplanned interim analysis revealed that the addition of durvalumab and olaparib was associated with a 37% improvement of PFS, compared with...
Conference Coverage
Surgical de-escalation passes clinical test in low-risk cervical cancer
‘Practice-changing’ results could reduce long-term survivor effects among qualifying patients.
From the Journals
Mailed HPV test kits boost cervical cancer screening
About 23% of eligible women are overdue for cervical cancer screening by at least a year.
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
From the Journals
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
Conference Coverage
AI predicts endometrial cancer recurrence
Model uses only digitized histopathology slides, but more validation in other populations is needed.
Latest News
Premenopausal women benefit from ovarian conservation with benign hysterectomies
Population-based study suggests that risks of bilateral salpingo-oophorectomy outweigh benefits for women younger than 45 years.
Latest News
Cervical screening often stops at 65, but should it?
A new study is intended to provide a more solid foundation for the benefits and harms of cervical screening for women older than 65.
Gynecologic Oncology Consult
Surgical management of borderline ovarian tumors, part 1
Ovarian-sparing procedures should be offered to patients in the setting of borderline ovarian tumors, with the understanding that they are...